CIK: 0001582844 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value ($000): $403,795 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXSM | AXSOME THERAPEUTICS INC | 607,500 | $62,791 | 15.6% | $23.68 | +70.6% | COM | 05464T104 |
| XBI | SPDR SERIES TRUST | 500,000 | $47,555 | 11.8% | — | — | Put | 78464A870 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 442,500 | $28,068 | 7.0% | $23.72 | +109.2% | COM | 04280A100 |
| — | KADMON HLDGS INC | 6,040,000 | $27,361 | 6.8% | $3.68 | — | COM | 48283N106 |
| AUPH | AURINIA PHARMACEUTICALS INC | 1,057,500 | $21,425 | 5.3% | $6.93 | +32.9% | COM | 05156V102 |
| — | INTRA CELLULAR THERAPIES INC | 587,089 | $20,143 | 5.0% | $34.31 | — | COM | 46116X101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 656,500 | $18,172 | 4.5% | $7.92 | +187.3% | COM | 462260100 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,322,500 | $15,235 | 3.8% | $11.52 | — | COM | 00773U108 |
| ARVN | ARVINAS INC | 356,000 | $14,628 | 3.6% | $19.30 | +51.7% | COM | 04335A105 |
| — | AVADEL PHARMACEUTICALS PLC | 1,625,000 | $12,269 | 3.0% | $7.55 | — | SPONSORED ADR | 05337M104 |
| XENE | XENON PHARMACEUTICALS INC | 917,500 | $12,028 | 3.0% | $8.16 | +29.0% | COM | 98420N105 |
| — | KARYOPHARM THERAPEUTICS INC | 590,000 | $11,310 | 2.8% | $15.33 | — | COM | 48576U106 |
| BCRX | BIOCRYST PHARMACEUTICALS | 2,825,000 | $9,746 | 2.4% | $2.52 | 0.0% | COM | 09058V103 |
| — | CONSTELLATION PHARMCETICLS I | 197,500 | $9,304 | 2.3% | $47.11 | — | COM | 210373106 |
| — | DICERNA PHARMACEUTICALS INC | 387,500 | $8,537 | 2.1% | $22.03 | — | COM | 253031108 |
| MIST | MILESTONE PHARMACEUTICALS IN | 508,500 | $8,141 | 2.0% | $19.80 | -10.3% | COM | 59935V107 |
| — | IVERIC BIO INC | 910,000 | $7,808 | 1.9% | $8.58 | — | COM | 46583P102 |
| — | REATA PHARMACEUTICALS INC | 38,000 | $7,768 | 1.9% | $80.29 | — | CL A | 75615P103 |
| — | BELLUS HEALTH INC NEW | 810,000 | $6,156 | 1.5% | $6.43 | — | COM NEW | 07987C204 |
| APLS | APELLIS PHARMACEUTICALS INC | 187,500 | $5,741 | 1.4% | $27.68 | 0.0% | COM | 03753U106 |
| — | SELECTA BIOSCIENCES INC | 2,364,204 | $5,345 | 1.3% | $2.26 | — | COM | 816212104 |
| — | NEOLEUKIN THERAPEUTICS INC | 372,500 | $4,589 | 1.1% | $12.32 | — | COM | 64049K104 |
| — | KARUNA THERAPEUTICS INC | 56,000 | $4,219 | 1.0% | $75.34 | — | COM | 48576A100 |
| — | APPLIED THERAPEUTICS INC | 148,000 | $4,037 | 1.0% | $18.14 | — | COM | 03828A101 |
| INSM | INSMED INC | 169,000 | $4,036 | 1.0% | $26.21 | -22.4% | COM PAR $.01 | 457669307 |
| — | INTRA CELLULAR THERAPIES INC | 100,000 | $3,431 | 0.8% | $34.31 | — | Call | 46116X101 |
| KURA | KURA ONCOLOGY INC | 240,000 | $3,300 | 0.8% | $16.00 | -7.4% | COM | 50127T109 |
| — | ZYMEWORKS INC | 70,500 | $3,205 | 0.8% | $30.08 | — | COM | 98985W102 |
| — | IMMUNOMEDICS INC | 150,000 | $3,174 | 0.8% | $21.16 | — | COM | 452907108 |
| ASND | ASCENDIS PHARMA A S | 22,500 | $3,130 | 0.8% | $139.11 | — | SPONSORED ADR | 04351P101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 107,500 | $1,915 | 0.5% | $13.85 | -5.8% | COM | 483497103 |
| — | MEDICINES CO | 21,700 | $1,843 | 0.5% | $84.93 | — | COM | 584688105 |
| QURE | UNIQURE NV | 25,000 | $1,792 | 0.4% | $54.91 | 0.0% | SHS | N90064101 |
| — | ACASTI PHARMA INC | 620,000 | $1,519 | 0.4% | $2.45 | — | CL A NEW | 00430K402 |
| — | CHEMOCENTRYX INC | 35,000 | $1,384 | 0.3% | $39.54 | — | COM | 16383L106 |
| — | ADVERUM BIOTECHNOLOGIES INC | 100,000 | $1,152 | 0.3% | $11.52 | — | Call | 00773U108 |
| — | ZAFGEN INC | 1,000,000 | $1,110 | 0.3% | $1.11 | — | COM | 98885E103 |
| — | X4 PHARMACEUTICALS INC | 40,000 | $428 | 0.1% | $10.70 | — | COM | 98420X103 |